Context: Lower neurocognitive development scores at age 2 yr have been reported in association with euthyroid hypothyroxinemia during early pregnancy.
F
etal central nervous system development relies on T 4 as a substrate for conversion to T 3 , the active form of thyroid hormone; T 3 does not cross the fetal blood-brain barrier (1) (2) (3) . Before 12 wk gestation, the mother is the sole source for T 4 , after which fetal production of T 4 begins and slowly increases. In 1976, Man and Serunian (4) presented preliminary evidence that low butanol-extractable iodine levels in mothers' serum at 24 wk gestation were associated with impaired psychomotor development in the offspring at age 7 yr. Butanol extractable iodine, an indirect measure of thyroid hormones, was used before the availability of more refined assays (i.e. TSH, T 4 , and free T 4 ). More recent studies, using these newer assays, again indicated that deficient maternal thyroid function can have an adverse impact on the offspring's neurocognitive development when a mother has either diagnosed (5) or undiagnosed (6) mild to moderate thyroid deficiency (as defined by elevated TSH) or isolated hypothyroxinemia associated with normal TSH (6 -10) . The present study further explores the extent to which isolated maternal hypothyroxinemia with normal TSH in midpregnancy in an iodine-sufficient region might be associated with the offspring's neurocognitive development by evaluating this relationship in the context of variables with known influence on child development.
Materials and Methods

Study subjects
The study protocol was approved by the Foundation for Blood Research (FBR) Institutional Review Board. Pregnant women presenting for second-trimester screening between May 2004 and March 2006 gave informed consent for the serum TSH measurement (at the time of serum screening for Down syndrome) and free T 4 (in stored sera, after pregnancy completion). This initial recruitment phase formed a cohort of pregnancies that would be sufficiently large to identify and enroll 100 women with isolated hypothyroxinemia (euthyroid women with free T 4 at the third centile or less) and 100 paired, matched euthyroxinemic women (euthyroid women with free T 4 between the 10th and 90th centiles). Serum TSH values of the euthyroid women ranged between 0.26 and 3.34 mIU/liter. Recruitment pool size was modeled by taking into account the known distributions of TSH and free T 4 in the Maine pregnant population, the proportion of infants expected to meet inclusion criteria, and the anticipated enrollment rate among women identified for further testing.
Birth record information was available through a data-sharing agreement between FBR and the Bureau of Vital Statistics, Maine Department of Health and Human Services. These data were linked to FBR's clinical patient records in two stages, approximately 1 yr apart, because offspring reached the age for psychometric testing over a 2-yr period. Women were excluded from the study if birth records or patient records indicated multiple gestation, delivery at less than 36 wk gestation, delivery of a baby with congenital anomalies, or a birth weight less than 2500 g.
At least three euthyroxinemic women were matched to each woman with isolated hypothyroxinemia. The seven matching criteria (in descending order of importance) were the child's sex (exact match required); maternal parity (exact match required); mother's years of education; child's age; mother's age; geographic location (northern, central, or southern Maine); and, among parous women, age of next oldest sibling (Ͻ2 yr, Ն 2 yr). The euthyroxinemic women were ranked in order of match stringency for each potential subject with isolated hypothyroxinemia, using assigned weights for each variable that reflected distance from an exact match. Based on stringency, euthyroxinemic women were matched either for all seven criteria (n ϭ 57), for six (n ϭ 28), for five (n ϭ 7), for four (n ϭ 6), or for one (n ϭ 1).
Women with isolated hypothyroxinemia were contacted by mail and follow-up phone call 1 month before their child's second birthday. Psychometric testing for the child was scheduled based on verbal consent; women gave written informed consent at the testing appointment for both the child's testing and access to their child's newborn thyroid screening data. Once a hypothyroxinemic woman was scheduled for testing, the contact and enrollment process began for a matched euthyroxinemic woman. Supplementary information about each child's health, including medical problems and hospitalizations, was systematically collected at the time of the visit for Bayley Scales of Infant Development, third edition (BSID III) testing. One matched pair was excluded from the present analyses due to a diagnosis of autism in a control child. No other cases of autism were reported in either cases or controls.
Laboratory measurements
Second-trimester maternal serum TSH levels were measured using an Immulite 2000 chemiluminescence analyzer (Siemens Healthcare Diagnostics, Deerfield, IL) with kits from the manufacturer. Maternal serum samples from euthyroid women were then stored at Ϫ20 C for the later measurement of free T 4 on the same platform. For the BSID III testing to be scheduled after the second birthday, it was necessary to enroll the children before they reached 2 yr of age. This, in turn, required that free T 4 Total T 4 and antithyroid peroxidase antibodies (TPO; positive result defined as Ն 35 IU/ml) were measured in stored second-trimester sera from the 198 women participating in the psychometric testing stage of the study, using the same platform. Neonatal total T 4 results for this group of pregnancies were obtained by blood spot measurements performed at the University of Massachusetts as part of Maine's newborn screening program (reference range, total T 4 Ͼ 5 g/dl). The data were provided to FBR by the Maine Genetics Program.
Although it was not possible to assess iodine status in our study population, National Health and Nutrition Examination Survey data indicate that iodine status is generally acceptable in the United States (11) . In an earlier analysis, we examined urine iodine data from nonpregnant adults in National Health and Nutrition Examination Survey III and determined that T 4 concentrations were not diminished in the presence of urine iodine concentrations between the first and ninth centiles (12) .
Neurocognitive testing
The BSID III (11) was administered to obtain standard scores for cognitive, language (receptive and expressive subtests), and motor (gross and fine subtests) scales. As described by Bayley (13) , the BSID III uses standardized administration and scoring procedures to provide the infant and toddler with situations and tasks that capture his or her interest and that provide an observable set of behavioral responses. The cognitive scale assesses play skills, information processing, information processing speed, problem solving, and number concepts. The language scale assesses both receptive (ability to hear, understand, and respond) and expressive (ability to communicate) language skills and is important for identifying critical delays. The motor subtests assess quality of movement, sensory and perceptual motor integration, and basic locomotion milestones. The BSID III composite test scores are scaled on a range of 40 -160, to have a mean of 100, and a SD of 15. Although not considered an intelligence quotient test, the Bayley Scales reliably identify infants with developmental delays, as indicated by scores less than 85 on the cognitive, language, or motor composite scores. Testing was performed by two individuals experienced in child developmental testing. Both the person scheduling the appointments and the testers themselves were blinded as to the thyroid status of the study subjects. Assignments for children to be tested were based on tester availability. All tests were double scored to ensure accuracy in calculating the age of the child, number of items passed, and conversion of raw scores to standard scores as published in the test manual. Two tests were administered to collect data about the child's environment: the Four Factor Index of Social Status (Hollingshead Scale) (14) , which measures family socioeconomic status (calculated from the educational and occupational status of both parents), and the Home Screening Questionnaire (HSQ) (15), which assesses the child's environment without requiring a home visit.
Data analysis
Data were analyzed using statistical software from the SAS Institute, Inc. (Cary, NC) and Analyze-It for Excel (Microsoft Inc., Seattle, WA). Hypothyroxinemic women who enrolled were compared with those who did not enroll using the 2 test, and the t test. Demographic and pregnancy-related data were compared between study subgroups, using the paired t test for continuous data and either the McNemar's test or Wilcoxon test, as appropriate, for categorical data. A linear model was fitted to predict the difference between each of the three BSID III scores for case/control sets, after controlling for gestational age, child's age at testing, maternal weight, and years of education. Significance was two sided at the P ϭ 0.05 level. The 95% confidence intervals were computed for the observed and adjusted differences in BSID III scores. To determine whether controls with free T 4 concentrations in the upper percentiles might score higher on BSID III testing, the 98 pairs were divided into two groups, according to free T 4 percentiles of controls (10th to 49th and 50th to 90th), allowing subanalyses to be performed. Table 1 documents the process for identifying eligible hypothyroxinemic and euthyroxinemic women among the 5734 women who participated in the recruitment phase of the study. After excluding 174 women who were not euthyroid (3%) and 1410 women with pregnancy outcomes and free T 4 levels that did not meet eligibility criteria (24%), 4150 euthyroid women remained. Among these women, 144 were identified with hypothyroxinemia, 99 of whom (68%) enrolled into the psychometric testing phase of the study. Reasons for nonenrollment included declining to participate or withdrawing from the study (n ϭ 21), moving out of state (n ϭ 13), inability to be contacted (n ϭ 9), and the child not living with the mother (n ϭ 2). Those not enrolled were significantly younger (P ϭ 0.002), had fewer years of education (P ϭ 0.003), were less likely to be white (88.9 vs. 98%, P ϭ 0.03), and were more likely to be primiparous (51.1 vs. 33.3%, P ϭ 0.03). Table 2 compares selected variables between case and control women and their offspring, with the six matching variables examined first. Matching was highly successful, as judged by comparing the distribution of differences cal- Chemistry test results are compared in the two groups in the bottom of Table 2 . Due to study selection criteria, free T 4 and total T 4 measurements were significantly lower among hypothyroxinemic women, as expected. TSH was slightly but significantly higher in the hypothyroxinemic subgroup. Percent of TPO antibody measurements 35 IU/liter or greater did not differ significantly between cases and controls. Among euthyroxinemic women in the lowest free T 4 quintile, median BMI was 29.5 kg/m 2 , as opposed to 24.6 kg/m 2 in the highest quintile (data not shown in Table 2 ).
Results
Identification of study groups
Description of study groups
Not shown are case-control comparisons for race and smoking. Consistent with Maine's racial distribution, 98% of cases and 99% of controls were white (P ϭ 0.1). Smoking rates also did not differ (9 and 8%, respectively, P ϭ 1.0). No enrolled child was identified with congenital hypothyroidism by newborn screening. Total T 4 , measured in newborn blood spots, was 17.3 g/dl [95% confidence interval (CI) 16.3-18.2] and 18.1 g/dl (95% CI: 17.2-18.9) in the hypothyroxinemic and euthyroxinemic groups, respectively; all subjects had total T 4 greater than 5 g/dl.
We found significant positive linear relationships between BSID III scores and three measures of socioeconomic status (Hollingshead score, HSQ score, mother's education) in both thyroid status subgroups (data not shown). These relationships are well known and reinforce the integrity of the data set. Negative linear associations were present between BMI and BSID III scores among control children (cognitive: r ϭ Ϫ0.215, P ϭ 0.036; language: r ϭ Ϫ0.279, P ϭ 0.006; motor: r ϭ 0.184, P ϭ 0.074). These relationships were not present among children of hypothyroxinemic mothers. Table 3 shows BSID III composite scores (cognitive, language, and motor) in 98 cases and controls. In this analysis, one case-control pair was removed, as the control child was diagnosed with autism. Unadjusted scores were lower among case children in all three domains. The mean matched differences reached borderline significance for cognitive and motor but not for language scores. Similar results were seen for both male (n ϭ 45 pairs) and female (n ϭ 53 pairs) offspring (data not shown). When the 98 pairs were divided into two groups, according to free T 4 percentiles of controls (10th to 49th and 50th to 90th), 
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there was no consistent relationship between differences in unadjusted scores and control free T 4 percentile range.
The analysis was performed again, accounting for paired differences in gestational age, child's age at testing, maternal weight, and years of education. Maternal weight was missing for seven women (five cases and two controls). To allow these subjects to be included in the analysis, they were assigned the average weight in their respective group. After adjustment, the mean matched differences for the 98 pairs were reduced in all three domains; all became nonsignificant. Among the free T 4 subgroups, differences between cases and controls lessened and remained nonsignificant. One or more BSID III cognitive, language, and/or motor composite scores less than 85 were obtained in 21 of 98 offspring of hypothyroxinemic women and 13 of 98 offspring of euthyroxinemic women (P ϭ 0.17). The same relationships were seen separately for cognitive (six vs. two), language (14 vs. 11), and motor scores (12 vs. five). Scores less than 70 were obtained in five offspring of hypothyroxinemic women and three offspring of euthyroxinemic women (P ϭ 0.73).
Discussion
The present data demonstrate that isolated hypothyroxinemia during the second trimester is not associated with meaningful changes in composite BSID III scores at age 2 yr, when compared with scores for the offspring of matched euthyroxinemic women. Although euthyroid maternal hypothyroxinemia is hypothesized to be reflected in the fetal circulation at this time in gestation, it is not possible to obtain comparative measurements directly from the fetus. Child neurodevelopment is influenced by multiple factors, which need to be considered when evaluating the effect of an environmental exposure (16) . Matching, although successful in minimizing differences for six potential confounders, does not eliminate potential confounding for others. Adjusting for these factors further reduced the small observed differences between the two subgroups.
In the current study, maternal weight (and BMI) both were higher among hypothyroxinemic women. Maternal weight was used to adjust the differences in scores because it had only seven missing results, compared with 14 missing results for BMI. Among euthyroxinemic women, the 4.9 kg/m 2 difference between women in the lowest and highest free T 4 quintiles is more pronounced than the free T 4 /BMI association reported in nonpregnant Australian adults, in whom BMI averaged 1.7 kg/m 2 higher in the lowest, as opposed to highest, quintile of free T 4 values (17) . As reported by others, we found that markers of socioeconomic status, including maternal age and education, had a positive association with offspring developmental scores, whereas maternal weight (or BMI) had weaker negative associations (18 -21) . The study reported by Pop et al. in 2003 (7) is most comparable with ours, in that it used a case-control design to examine neurocognitive development among offspring of euthyroid hypothyroxinemic women. Although neither study measured iodine concentrations in maternal urine, populations in both regions are generally considered io- (9) reported a relationship between low first-trimester maternal levels of free T 4 and cognitive delay among the offspring of hypothyroxinemic euthyroid Dutch women. However, the study's cross-sectional design and type of child evaluation (a self-administered structured parental report) complicate direct comparison with our data.
Using an earlier version of the Bayley Scale of Infant Development (second edition), Pop et al. (6) found that overall mental and motor scores among offspring of hypothyroxinemic mothers at age 1 and 2 yr were significantly lower than controls (by eight to 10 points). Although our results are in the same direction, our effect size is approximately 3-to 4-fold smaller. Differences in population make-up are unlikely to explain the different findings. The study population in the report by Pop et al. was described as Dutch Caucasian, and ours is 98% white. Design differences between the two studies, however, might account for at least a portion of the discrepancy. Pop et al. (7) obtained free T 4 measurements at 12 wk gestation and followed up with measurements at 24 and 32 wk. Initial measurements made in the first trimester might be more strongly associated with offspring performance. It should be noted, however, that subsequent shifts in free T 4 percentiles at 24 and 32 wk did not dilute the association with mental/motor development, as determined from the 12-wk measurements. In that study, matching was limited to parity and gravidity, and adjustments were not made for socioeconomic status (high incomes were reported for 49% of families in the euthyroxinemic group vs. 39% in the hypothyroxinemic group). Socioeconomic status is an important factor for child development (16, 19, 22) , and this could result in a bias that favors higher performance in controls. Differences in the rates of TPO antibody positivity between the two studies might also influence results. Among euthyroxinemic women in our study, 10.1% were TPO antibody positive, as opposed to 14.1% of hypothyroxinemic women. Corresponding figures for The Netherlands study are 4.2 and 16.7% (8) , suggesting further health differences between case and control women. In addition, The Netherlands study classified free T 4 measurements below the 10th centile as hypothyroxinemia, whereas controls were selected from women with free T 4 measurements between the 50th and 90th centiles. To explore whether this might explain differing findings between the two studies, we compared BSID III scores of our controls whose mothers' free T 4 measurements were between the 50th and 90th centiles with those of their matched cases (Table 3) . Our results were unchanged.
The concept of screening pregnant women for subclinical thyroid deficiency is controversial (23, 24) , and discussion has focused primarily on identifying women with elevated TSH measurements with known adverse clinical consequences for the mother and fetus (25) (26) (27) (28) (29) . Further data are needed, including evaluation of older children, for both subclinical hypothyroidism and isolated hypothyroxinemia before the screening debate can be resolved. Although addressing hypothyroxinemia, the results of this study cannot be extrapolated to children of mothers with subclinical hypothyroidism. Two randomized controlled trials are currently underway that address this subject: the Controlled Antenatal Thyroid Screening Study (ISTCTN46178175) and Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy (NCT00388297). Our study shows that any impairment in neurocognitive development among the offspring of women with isolated hypothyroxinemia in the second trimester of pregnancy would be, at most, small. It also reinforces, however, the importance of accounting for other, more dominant, factors influencing child development in study design and analysis.
